Stability Testing Requirements for New Drug Applications (NDAs)
Stability testing is a critical component of new drug applications (NDAs), providing essential data to support the quality, safety, and efficacy of pharmaceutical products. Regulatory agencies, such as the U.S. Food and Drug Administration (FDA) and the European Medicines Agency (EMA), have established specific requirements for stability testing as part of the NDA submission process….
Read More “Stability Testing Requirements for New Drug Applications (NDAs)” »